What Is the KLOW Peptide Blend? Research Overview

KLOW is a four-peptide research blend and one of the most-searched names in skin and tissue-repair research. Instead of a single sequence, each vial combines four compounds that are usually studied on their own: BPC-157, TB-500, GHK-Cu and KPV. This overview covers what the KLOW peptide is, what it's made of, what each component does at the mechanism level, and why the four are combined in tissue-repair, inflammation and skin-biology models. For in-vitro laboratory research only.

What is the KLOW peptide?

KLOW is a fixed combination of four research peptides lyophilized together in one vial. Online it's often called the KLOW peptide or the KLOW stack, but in the laboratory it's better understood as a combined panel: four mechanistically distinct compounds, supplied as a single reference material, for study designs that look at several repair-related pathways at once. The KLOW blend sits in Eon's cosmetic and skin research category, though its components reach into recovery and inflammation research as well.

What is KLOW made of?

Per the product record, each KLOW vial contains four peptides:

• BPC-157 (10mg): a synthetic 15-amino-acid peptide derived from a protective protein sequence in gastric juice
• TB-500 (10mg): a synthetic fragment of Thymosin Beta-4, the actin-binding protein found in nearly all cell types
• GHK-Cu (50mg): the copper(II) complex of the glycine-histidine-lysine tripeptide
• KPV (10mg): the lysine-proline-valine tripeptide that forms the C-terminal end of alpha-MSH

That's 80mg of combined peptide per vial, with GHK-Cu the largest component by mass. The ratio is fixed by the blend, so a study that needs to vary one component separately from the others is better served by the individual reference standards.

What does each KLOW component do in research models?

The case for the combination rests on the four compounds sitting on different mechanistic axes. Each has its own research guide; here is how they differ at the mechanism level.

BPC-157: angiogenesis and structural repair

BPC-157 is studied mostly in angiogenesis and structural-repair models. Published work associates it with VEGFR2 signaling and the nitric-oxide system in endothelial assays, and animal-model studies have examined it in tendon, ligament, muscle and gastrointestinal repair. Its stability in aqueous and acidic conditions is part of why it became a standard research model. See what is BPC-157 for the full overview.

TB-500: actin regulation and cell migration

TB-500 reproduces the actin-binding region of Thymosin Beta-4. By sequestering G-actin, the monomer that builds the cytoskeleton, it's examined for how it shifts filament dynamics and, through them, cell migration in scratch and wound-closure assays. Its research footprint is cell movement rather than vessel growth or matrix synthesis. See what is TB-500.

GHK-Cu: copper-dependent matrix remodeling

GHK-Cu is the most-studied compound in skin-biology research. The copper it carries is a cofactor for enzymes such as lysyl oxidase, which cross-links collagen and elastin, and fibroblast studies examine its influence on collagen synthesis and on the balance between matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs). The GHK-Cu research guide covers this in depth.

KPV: inflammatory signaling

KPV is the C-terminal tripeptide of alpha-MSH, studied as the minimal fragment that keeps the hormone's anti-inflammatory signal without its pigmentation-related activity. Cell-based work centers on NF-kB translocation and on pro-inflammatory cytokine output, such as IL-6 and TNF-alpha, in epithelial and intestinal inflammation models. See what is KPV.

What is KLOW studied for? Why the four are combined

Tissue repair is usually modeled as overlapping phases: an inflammatory phase, a proliferative phase in which cells migrate and new vessels form, and a remodeling phase in which the extracellular matrix is rebuilt and reorganized. Each KLOW component maps onto a different part of that sequence:

• Inflammatory signaling: KPV, in NF-kB and cytokine models
• Cell migration: TB-500, in actin and migration assays
• Angiogenesis and structural repair: BPC-157, in endothelial and tendon models
• Matrix remodeling and collagen synthesis: GHK-Cu, in fibroblast and MMP/TIMP models

That spread is the rationale for the blend. A study interested in the whole repair sequence, or in how pathways interact across it, can work from one reference material instead of four. It also explains why KLOW appears in both tissue-repair and skin-biology research: GHK-Cu and KPV anchor the matrix and inflammation side, while BPC-157 and TB-500 anchor structural repair and cell migration. For the wider categories, see injury and tissue-repair research peptides and skin and hair research peptides.

The trade-off: attribution

A combined panel carries one methodological cost. When four compounds are present together, an effect observed in a model can't be assigned to any one of them without comparison arms. Careful designs pair the blend with the single-compound reference standards, running each component alone so that any interaction between them can be separated from what each does by itself. That's why all four components are also supplied individually.

KLOW vs GLOW and KLOW vs Wolverine

KLOW vs GLOW

GLOW is the three-peptide counterpart: GHK-Cu (50mg), BPC-157 (10mg) and TB-500 (10mg) per vial, 70mg combined. KLOW is the same three at the same amounts plus KPV (10mg), 80mg combined, which adds a dedicated inflammatory-signaling component. See what is the GLOW peptide blend for the full overview, or compare the GLOW research blend listing side by side.

KLOW vs Wolverine (BPC-157 + TB-500)

"Wolverine" is an informal name for the pairing of BPC-157 and TB-500. Both are inside KLOW, so the difference is what KLOW adds: GHK-Cu's copper and matrix-remodeling biology, and KPV's inflammatory signaling. A study focused on structural repair and cell migration alone fits the two-peptide BPC-157 + TB-500 blend; one that also wants the matrix and inflammation arms fits the KLOW blend. The BPC-157 + TB-500 stack overview explains why that pair is so often studied together.

KLOW half-life and stability

There is no single half-life for KLOW. It's four separate peptides, each with its own size and stability profile, so a KLOW half-life chart would really be four unrelated figures. Published pharmacokinetic data for the individual compounds depend on model and formulation and don't transfer to research material, so we don't reproduce them here. For in-vitro work the practical stability questions are storage and handling: keep the lyophilized blend cold, dry and out of light until reconstitution. See how to store research peptides.

How KLOW is supplied

Eon supplies the KLOW Research Kit lyophilized, with all four peptides in each vial, shipped from our US facility with tracking and a printed lot number on each vial. Reconstitute for in-vitro use with bacteriostatic water following how to reconstitute peptides. As with GHK-Cu on its own, the copper complex typically gives the reconstituted blend a blue tint. Because its four components differ in mass, KLOW has no per-compound calculator page; the general peptide reconstitution calculator computes concentration for any component's mass and diluent volume.